Human recombinant DNase in cystic fibrosis.
Thomson
A H
AH
Department of Paediatrics, John Radcliffe Hospital, Headington, Oxford.
D000293:Adolescent; D000328:Adult; D002648:Child; D003362:Cost-Benefit Analysis; D003550:Cystic Fibrosis / Q000188:drug therapy* / Q000503:physiopathology; D003850:Deoxyribonuclease I / Q000627:therapeutic use*; D006801:Humans; D008168:Lung / Q000503:physiopathology; D009330:Nebulizers and Vaporizers; D018579:Patient Selection; D011788:Quality of Life; D011994:Recombinant Proteins / Q000627:therapeutic use; D012141:Respiratory Tract Infections / Q000517:prevention & control
D011994:Recombinant Proteins; C085693:DNASE1 protein, human; D003850:Deoxyribonuclease I